**Question:** All of the following are true for patients with ulcerative colitis associated with primary sclerosing cholangitis (PSC), Except

A. Increased risk of liver-related complications
B. Improved prognosis compared to isolated ulcerative colitis
C. Similar risk of colorectal cancer as in non-PSC UC
D. Better response to corticosteroids in PSC-UC patients

**Correct Answer: B. Improved prognosis compared to isolated ulcerative colitis**

**Core Concept:**
Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) characterized by inflammation of the colon, while primary sclerosing cholangitis (PSC) is a chronic liver disease involving the bile ducts. When these two conditions occur together in the same patient (PSC-UC), it is referred to as primary sclerosing cholangitis-associated ulcerative colitis (PSC-UC).

**Why the Correct Answer is Right:**
In PSC-UC patients, the prognosis may not necessarily be better compared to isolated UC patients. Although the combination of PSC and UC can increase the risk of liver-related complications and colorectal cancer, the overall prognosis is not always improved. In fact, some studies suggest that PSC-UC patients may have an increased risk of liver-related complications due to the presence of PSC.

**Why Each Wrong Option is Incorrect:**

**A. Increased risk of liver-related complications:** As mentioned, patients with PSC-UC do have an increased risk for liver-related complications. This option is incorrect because it is true for these patients, not false.

**C. Similar risk of colorectal cancer as in non-PSC UC:** While the risk of colorectal cancer is higher in PSC-UC patients compared to those with isolated UC, this option is incorrect because it suggests a similar risk, which is not the case.

**D. Better response to corticosteroids in PSC-UC patients:** In some cases, PSC-UC patients may have a better response to corticosteroids compared to isolated UC patients. However, this statement is not universally true, and the overall response to corticosteroids can be similar to isolated UC patients. This option is incorrect because it implies a consistent improvement in response to corticosteroids, which cannot be assumed without considering individual patient factors and treatment response.

**Clinical Pearl:**

While the presence of PSC complicates the management of UC, patients with PSC-UC often require more aggressive treatment strategies, including biologic agents, due to their increased risk of liver-related complications and colorectal cancer. The response to treatment should be assessed individually and not generalized.

**Why Correct Answer B is Right:**

The correct answer is B, "Better response to corticosteroids in PSC-UC patients," because it is a common misconception that PSC-UC patients generally have a better response to corticosteroids compared to isolated UC patients. This misconception arises from the fact that PSC can exacerbate the inflammation of the colon in UC, leading to more severe disease presentation and potentially more aggressive clinical course. However,